Kobo Biotech Ltd: Annual Report 2023-24 Filed Amidst CIRP

Kobo Biotech Ltd has filed its Annual Report for the Financial Year 2023-24, as per SEBI regulations. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) following an application by JM Financial Asset Reconstruction Company Limited. Ms. Namrata Amol Randeri has been appointed as the Resolution Professional and is managing the company's affairs. The 31st Annual General Meeting is scheduled for July 24, 2026, to adopt the audited financial statements and related reports. The Board of Directors' powers remain suspended and are exercised by the Resolution Professional.